Biostat (United States)

Recent papers from Biostat (United States)

1. Beyond prediction intervals in meta-analysis: reporting the expected proportion of comparable studies with clinically relevant benefit or harmBMC Medical Research Methodology · 2025
2. First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306Advances in Therapy · 2025
3. Systematic Reviews and Meta-Analyses in Regional Anesthesia and Pain MedicineAnesthesia & Analgesia · 2024
4. How to understand and report heterogeneity in a meta-analysis: The difference between I-squared and prediction intervalsIntegrative Medicine Research · 2023
5. Avoiding common mistakes in meta‐analysis: Understanding the distinct roles of Q, I‐squared, tau‐squared, and the prediction interval in reporting heterogeneityResearch Synthesis Methods · 2023
6. Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trialBritish Journal of Cancer · 2023
7. Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialLiver Cancer · 2022
8. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analysesCanadian Medical Association Journal · 2020
9. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional studyBMJ Open · 2020
10. Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell LymphomaHematological Oncology · 2019
11. A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumorsAnnals of Oncology · 2018
12. Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 CellsFrontiers in Immunology · 2018
13. Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management StudyDiabetes Technology & Therapeutics · 2017
14. Basics of meta‐analysis: I² is not an absolute measure of heterogeneityResearch Synthesis Methods · 2017
15. Single-Cell Cytokine Gene Expression in Peripheral Blood Cells Correlates with Latent Tuberculosis StatusPLoS ONE · 2015
16. Multi-institutional analysis of bioimpedance spectroscopy in the early detection of breast cancer related lymphedemaJournal of Cancer Research & Therapy · 2013
17. Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRPDiabetes Care · 2013
18. Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized TrialsSchizophrenia Bulletin · 2012
19. Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose DataDiabetes Care · 2012
20. A Structured Self-Monitoring of Blood Glucose Approach in Type 2 Diabetes Encourages More Frequent, Intensive, and Effective Physician Interventions: Results from the STeP StudyDiabetes Technology & Therapeutics · 2011